Ana Vujovic is a postdoctoral research fellow at the University of Colorado Anschutz Medical Campus. She completed her PhD under the mentorship of Dr. Kristin Hope at the University of Toronto and Princess Margaret Cancer Centre, University Health Network, where she studied the role of post-transcriptional regulation in hematopoietic and acute myeloid leukemia (AML) stem cells. Ana joined the laboratory of Dr. Craig T. Jordan in the Spring of 2023, where her postdoctoral studies are focused on investigating metabolic vulnerabilities in AML stem cells and in particular mechanisms that underlie the resistance of these cells to the combination therapy, Venetoclax and Azacitidine (Ven/Aza). The objective of her postdoctoral research is to identify novel therapeutic strategies to uniquely target the metabolic vulnerabilities of Ven/Aza-resistant AML stem cells with the goal of improving AML patient outcomes.